In addition to T cell differentiation in the thymus, we have recently reported that extrathymic T cell differentiation occurs preferentially in the sinusoids of the liver. Although this extrathymic pathway is relatively minor in normal mice, it becomes predominant in mice with autoimmune diseases, athymic mice, and aged mice. In the present study, injection of normal male C3H/He mice, 6-8 wk of age, with 1 mg of estrogen resulted in an increase in mononuclear cells (MNC) yielded from the liver and a drastic decrease in thymocytes approximately 10 d after such injection. This unique modulation was not observed with hydrocortisone injection (5 rag/mouse, i.p.) nor with irradiation (5 Gy/mouse). Rather, these immunosuppressive treatments induced a simultaneous decrease in cell number in both the liver and thymus. A time-kinetics study on the cell number and spontaneous cell proliferation revealed that an increase in spontaneous cell proliferation in the liver preceded the increase in the number of liver MNC, and a decrease in spontaneous cell proliferation in the thymus preceded the decrease in the number of thymocytes.
M
any clinicians and investigators have observed that the female has a greater propensity for the occurrence of various autoimmune diseases than the male. Actual diseases and female-to-male ratios showing a female predominance of autoimmune diseases were reviewed in both humans and animals (1) . Although the mechanisms underlying this sex difference are imperfectly understood, it has been suspected that sex hormones might be directly or indirectly associated with this phenomenon. In this respect, estrogen has often been suggested as one of the most probable candidates. For example, abnormal estrogen metabolism resulting in prolonged estrogenic stimulation induced or deteriorated diseased states in SLE patients (2) and administration of oral contraceptives (containing estrogen) to SLE patients exacerbated the disease (3, 4) . In experimental animals, estrogen administration was also reported to accelerate autoimmune diseases (5, 6) . In parallel with these observations, intensive studies on the immunological effects of estrogen have been reported (7) (8) (9) (10) . It was, however, noticed that the effects of estrogen on the immune system so far described did not sufficiently elucidate possible mechanisms of sex hormones involved in the occurrence of autoimmune diseases. It was therein reported that estrogen administration induced profound thymic atrophy and resulted in immunosuppressive effects on the peripheral immune systems. It seems that many difficulties face attempts to clarify the relation between the mechanisms involved in immunosuppression and autoimmune states. Moreover, estrogen administration has been found to sometimes inhibit certain autoimmune diseases, i.e., experimental autoimmune encephalomyelitis (11) and experimental autoimmune thyroidiris (12, 13) . It is, therefore, expected that more appropriate or different approaches should be applied to resolve confusion in this area.
It is widely known that T cells differentiate in the thymus and go through a process of either positive or negative selection to form the repertoires of mature T cells (14) (15) (16) (17) . In addition to this intrathymic pathway of T cell differentiation, we have recently demonstrated that both ot/~ and 3'//i T cells may differentiate extrathymically in the liver of humans and mice (18, 19) . Although the hepatic pathway of T cell differentiation is relatively minor in normal mice, this pathway becomes predominant in mice subjected to bacterial stimulation (20) , in mice with malignancies (21) , in autoimmune
MILblpr/Ipr mice (18) , in congenitally athymic nude mice, and in aged mice with involuted thymus (22) . ot/B T ceils that differentiate in the liver have several unique properties: (a) even forbidden T cell oligoclones could be generated after bacterial stimulation probably due to the lack of the doublepositive (DP) 1 CD4+8 + stage for negative selection (20) ; (b) V/~8 + cells, which are known to be intimately related to various autoimmune disease mice, were preferentially generated (23); and (c) the majority of extrathymic ot/B T cells residing in the liver had an intermediate intensity of TCRs (23) . It is conceivable that extrathymic c~/~/T cells may be important in the surveillance of bacterially infected cells and atypical cells generated in vivo, and that an overstimulation of such T cells (by undetermined causes) may be responsible for the onset of autoimmune diseases.
The object of the present study was to investigate how estrogen administration affects extrathymic T cell differentiation in the liver. It was demonstrated that estrogen administration might profoundly activate the extrathymic process of T cell differentiation in the liver and, instead, suppress the intrathymic process in the thymus. The possible dose relation of the present findings to the mechanisms involved in the female preponderance of autoimmune diseases is discussed.
Materials and Methods
Mice. Male C3H/He mice (H-2 k, Mls-2a), aged 6-8 wk, were obtained from Charles R.iver Japan Inc. (Tokyo, Japan). They were fed under specific pathogen-free conditions (19, 20) .
Estrogen Administration. I mg of estrogen (Ovahormone depo;
Teikoku Zoki, Inc., Japan)/mouse was subcutaneously injected. As estrogen is dissolved in sesame oil (i.e., due to being water insoluble), only the subcutaneous injection, but not the intravenous or intraperitoneal routes, is available. To investigate the unique effects of estrogen, mice injected intraperitoneally with hydrocortisone (5 rag/mouse; Sigma Chemical Co., St. Louis, MO) and mice irradiated with 5 Gy were also used.
Cell Preparation. Treated and untreated mice were killed, and mononuclear ceils (MNC) were prepared from the liver, thymus, and spleen. Liver MNC were obtained as previously described (19, 20) . Briefly, to eliminate blood from the liver before its removal, it was perfused with 10 ml PBS (0.01 M, pH 7.2) via the portal vein. To obtain MNC, the liver was pressed through 100-gauge stainless steel mesh and suspended in RPMI 1640 supplemented with 5% FCS. After one washing with the medium, the cells were resuspended in 20 ml of the medium and MNC were isolated from 1 Abbreviations used in this paper: DN, double negative; DP, double positive; MNC, mononudear cells. parenchymal hepatocytes by Ficoll-Isopaque density (1.090) gradient centrifugation. In the MNC preparation method applied here, the proportion of contaminated Kupffer cells was negligible (<4%). The cell yield was '~10-15% (18) . MNC of the spleen were also collected by the Ficoll-Isopaque method, whereas thymocytes were obtained by forcing the thymus through 100-gauge mesh (19, 20) .
CellProliferation Assay. The activity of spontaneous cell proliferation was analyzed by [3H]thymidine uptake into DNA (19) . Briefly, freshly isolated MNC (5 x l0 s cells/0.2 ml medium) were cultured in a 96-well round-bottomed microplate (Falcon Labware, Oxnard, CA) for 18 h at 37"C in a CO2 incubator. 0.5 gCi of I3H]thymidine (Amersham International, Amersham, England) was added at the initiation of culture. The medium used here was RPMI 1640 supplemented with 1% fresh mouse serum and 5 x 10 -s M 2-ME. The data express the mean cpm _+ 1 SD of triplicate cultures.
Immunofluorescence Test. Surface phenotypes ofceUs were identified by using mAbs in conjunction with the single-or two-color immunofluorescence test (18) (19) (20) . The mAbs used here included biotin-conjugated hamster anti-~/B-TCR (H57-597) (24) , FITCconjugated mouse anti-V~8 (F23.1) (25), FITC-conjugated hamster anti-CD3 (145-2Cll), unconjugated hamster anti-VO3 (KJ25-606-4) (26), and biotin-conjugated Ib2R/~ chain (TM-/~I) (kindly provided from Drs. T. Tanaka and M. Miyasaka, The Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan) mAbs (27) . Biotin-conjugated reagent was developed with PE-conjugated avidin, and unconjugated reagent was developed with PE-conjugated goat anti-hamster Ig (Caltag Laboratories, San Francisco, CA). FITCconjugated rat anti-CD4 (L3T4) and PE-conjugated anti-CD8 
Results

Unique Effects of Estrogen on the Number of MNC in the Liver
and Thymus. When C3H/He mice were subcutaneously injected with estrogen (1 rag/mouse), a prominent increase of the number of MNC obtained from the liver was demonstrated 10 d after the injection (Fig. 1 ). In contrast, severe thymic atrophy and resulting decrease in the number of thymocytes occurred at the same time. To emphasize this unique effect of estrogen, we also examined the number of MNC in the liver and thymus of mice injected with hydrocortisone (5 rag/mouse) or of mice irradiated with 5 Gy, which are known to be representative immunosuppressive treatments. After 5 d of these treatments, simultaneous decreases in the number of MNC in the liver and thymus occurred. The suppressive effect of hydrocortisone (5 mg/ml) was induced by both intraperitoneal and subcutaneous routes of injection (our unpublished observation). The maximum suppression was also achieved by both routes 5 d after the injection.
Time-Kinetics of Variations in the Number of MNC in the Liveg, Thymus, and Spleen after Estrogen Administration. Precise time-
kinetics of variations in the number of MNC was then analyzed (Fig. 2) . After 5 d of estrogen administration, the number of MNC in the liver began to increase, reached a peak on day 13, and then decreased gradually. The variation in the number of thymocytes appeared to be completely reversed, since the number of thymocytes began to decrease 3 d after the injection, reached a base line on day 7, and then showed a gradual restoration 15 d after the injection. A pattern of variation similar to that seen in the thymus was also observed in the spleen, although the variation was not so drastic as that in the thymus.
Reciprocal Change between the Liver and Thymus Was also Observed in Spontaneous Cell
Proliferation. in contrast to lymphocytes obtained from the peripheral immune organs, spleen, and lymph nodes, thymocytes and freshly isolated hepatic MNC often showed increased spontaneous cell proliferation in in vitro culture (18, 21) . This spontaneous cell proliferation was serially analyzed in the liver and thymus after estrogen administration (Fig. 3) . Interestingly, an increase in spontaneous proliferation of the hepatic MNC was observed to coincide with the period when the number of MNC increased. On the other hand, the spontaneous proliferation of thymocytes disappeared coincident with the time when the number of thymocytes was at the base line. Strictly speaking, an increase in the spontaneous cell proliferation in the liver seemed to slightly precede the increase in the number of MNC, whereas a decrease in the spontaneous cell proliferation in the thymus seemed to precede the decrease in the number of thymocytes.
Specific Activation of et/# T Cells with Intermediate TCR in
the Liver. It was previously reported that MNC in the liver contained a large population of ol/B T ceUs with either intermediate TCK or bright TCK (20, 23) . The staining pattern of TCK, V/38, CD3, and V~3 antigens was analyzed in the liver MNC before and after the injection (Fig. 4) . It was confirmed that or//3 T cells in the liver consisted of both intermediate TCR (or CD3) and bright TCK (or CD3). The former cells were a relatively minor population in the liver as compared with the latter cells in untreated control mice. 10 d after injection, almost all T cells were composed of intermediate TCK. This pattern was quite similar to that seen in the liver of autoimmune MRL-Ipr/Ipr mice and thymectomized mice as we previously reported (23) .
In a recent study, we developed the most accurate method to identify intermediate TCK ceils by a two-color immunofluorescence test using anti-CD3 and anti-Ib2RB mAbs (H. Watanabe, manuscript in preparation). By applying this method, we investigated the kinetics of estrogen dose and the time course in hepatic MNC (Fig. 5) . The results on days 5 and 10 are represented and the doses used here were 0.125, 0.25, 0.5, and 1 mg/mouse of estrogen. We noticed that the time course after estrogen administration showed the delayed onset (approximately several days after the injection) and longlasting effect, especially at the high doses, were probably due to the effect of the oil solvent or the intrinsic property of estrogen. As intermediate TCK cells (encompassed by squares in Fig. 5 The proportion of V33 + cells, which are reactive to Mls-2 ~ and are therefore one of the forbidden T cell oligo clones for C3H/He (Mls-2 ~) mice, was also analyzed in the liver before and after estrogen administration (see Fig. 4 , right, and Table 2 ). As expected, V~3 + cells were a negligible proportion (<1%) in all immune organs tested before estrogen administration. On the other hand, a significant proportion of V33 + cells (8.9 -1.2%; n = 4) appeared only in the liver after injection, ol/3 T cells with intermediate Table 2 . TCR also appeared only in the liver, and V33 + cells were shown to reside in this fraction. (14) (15) (16) (17) . The former cells are mainly immature DP CD4 + 8 + cells before a negative or positive selection process, and the latter cells are mature single-positive CD4 + or CD8 + cells after the selection process. As thymic atrophy and the resulting thymocytopenia were the most prominent findings in mice injected with estrogen, we finally investigated what type of cells specifically decreased at this time (Fig. 6) . A drastic decrease in the proportion of dull TCR cells was demonstrated by the staining of both od B-TCR and CD3. Although the relative proportion of bright TCR cells in the thymus increased after estrogen treatment, calculation showed the absolute number of such bright TCR cells was also shown to decrease (up to 1:5).
An Increase of VflS+/w_/'I?-TCR + Ratios and Generation of Forbidden T Cell Oligoclones after Estrogen
Generation of V~3 + Forbidden T Cell Clone in the Liver after Estrogen Injection
Disappearance of DP ~z/ff T Cells with Dull TCR in the Thymus after Estrogen Administration. It is well established that cx/B T cells in the thymus consist of both dull TCR cells and bright TCR cells
A two-color immunofluorescence test of CD4 and CD8 staining in the thymus was then analyzed (Fig. 7) . As anticipated, DP CD4+8 + cells selectively decreased (80.5 to 35.0%) after a single injection of estrogen. This fraction corresponded to dull TCR cells in the former experiment. If estrogen administration was repeated more than twice every other day, the proportion of DP CD4 + 8 + ceils decreased to the basal level (<1%) (data not shown).
Discussion
In the present study, we demonstrated that estrogen administration stimulated extrathymic T cell differentiation in the liver of mice in terms of the increased MNC number mice, and V/~8 + T cells, both of which were, although not entirely, previously characterized as extrathymic T cells with unique properties seen in the liver of mice under autoimmune conditions (18, 23) and malignancies (19, 21) . On the other hand, estrogen administration appeared to suppress intrathymic T cell differentiation in terms of the decreased thymocyte number and the disappearance of immature DP CD4+8 + cr T cells with dull TCRs. As an overactivation of the extrathymic pathway of T cell differentiation might be responsible for a possible induction or acceleration of autoimmune diseases, the present findings might elucidate the immunological basis of the mechanisms involved in the female predominance of autoimmune diseases. Several investigators have proposed the existence of an extrathymic pathway for T cell differentiation in experiments utilizing congenitally athymic nude mice (28) (29) (30) and in vitro culture systems (31, 32) . However, a consensus has not yet been reached, since there is no definite information as to where such T cells differentiate outside the thymus. We have recently reported that such ot/~ (and 3'//~) T cells differentiate preferentially in the sinusoids of the liver, especially under conditions of autoimmune diseases (18, 23) , malignancies (19, 21) , bacterial stimulations (20) , and aging (22) . The extrathymic o~/~ T cells generated in the liver have several unique properties not seen in those differentiated in the thymus. In the liver as well as in the thymus, o~/~ T cells show a twopeak pattern of dull and bright TCR expression (including CD3 antigens) in terms of immunofluorescence staining intensity (20) . A single-peak pattern of only bright o#~-TCR and CD3 is seen in other peripheral immune organs, including the spleen, lymph nodes, peripheral blood, intestine, and skin. However, the peak of hepatic dull TCR should be estimated as "intermediate" because it is somewhat brighter than thymic dull TCR (23) (18, 20, 23) . It is therefore, conceivable that extrathymic c~/B T cells lack a process of negative selection and that forbidden T cell clones are therefore generated in the liver. In addition, only hepatic c~/B T cells with intermediate TCRs comprise a high proportion (>60%) of V/~8 + cell oligoclones (normal values are "~30%) (23) . VB8 + cells have recently been well characterized as the cells responsible for the onset of autoimmune disease due to their autoreactivity (34) . Their roles in the onset of diseases in autoimmune mice, e.g., MRDlpr/Ipr mice (23), mice with experimental autoimmune encephalomyelitis (35, 36) , and diabetic NOD mice (37) , have been reported.
Concerning the above evidence from our recent studies, we prefer to consider that estrogen administration activates an extrathymic pathway of T cell differentiation in the liver. Our subsequent study further demonstrated that repeated injections of lower doses of estrogen could induce continuous activation of the hepatic pathway of T cell differentiation (unpublished observation). It is conceivable that such activated, extrathymic c~//~ T cells, which contain a large population of VB8 + cells and considerable proportions of forbidden T cell oligoclones, may be responsible for the induction or acceleration of certain autoimmune diseases.
We recently examined the estrogen effects on the extrathymic T cell differentiation in the liver of athymic nude BALB/c-nu/nu mice aged 8 and 20 wk (data not shown).
In contrast to our expectation, we could not produce a significant augmentation of extrathymic T cell differentiation by estrogen (1 mg/mouse, s.c.) in terms of changes in the number of hepatic MHC and the proportion of intermediate TCR cells. Although we will report that athymic nude mice have only intermediate TCR cells in the liver and, to some extent, in the periphery, the absolute number of such cells is not high (33) . It is probably that nude mice may not have the best microenvironments even for the extrathymic T cell differentiation in the liver.
We also confirmed a drastic decrease of thymocyte number after estrogen administration. Many earlier studies on the immunological effects of estrogen demonstrated a rapid induction of thymic atrophy and the subsequent decrease of T lymphocytes in the peripheral immune organs (8, (38) (39) (40) . In the present study, we clearly showed that such a rapid decrease in the number of thymocytes was mainly caused by the selective disappearance of immature DP CD4+8 + c~/~ T cells with dull TCR. We have further demonstrated that the disappearance of each DP ot/~ T cell was due to an acceleration of the apoptosis normally seen in the thymus (our unpublished observation). It is noteworthy that activation of extrathymic T cell differentiation in the liver is always accompanied by an inactivation of intrathymic T cell differentiation, i.e., aging (22) , malignancies (21) , bacterial stimulations (20) , and estrogen administration. It is conceivable that the extrathymic and intrathymic pathways for T cell differentiation may be reciprocally regulated by undetermined factors. The mechanisms underlying this phenomenon are under investigation. We have recently noticed that estrogen administration may activate stromal cells in the thymus (i.e., thymic epithelial cells) and possibly stromal cells in the liver (i.e., sinusoidal endothelial cells and Kupffer cells), probably via their estrogen receptors on the cell surface (41, 42) .
There were reports that estrogen administration inhibited the onset of certain autoimmune diseases (11-13), i.e., experimental autoimmune encephalomyelitis and thyroiditis. In contrast to the spontaneous onset of many autoimmune diseases, those experimental diseases were caused by the injection of foreign antigens (even if they mimic autoantigens).
It is conceivable that at least during the period of onset, such experimental diseases might be important for o~/B T ceUs generated intrathymically. If this is the case, estrogen administration is expected to act as an inhibitory factor due to its suppressive effect on the intrathymic pathway ofT cell differentiation. Our present findings may explain some of the conflicting effects of estrogen administration on autoimmune diseases.
A question is raised as to how estrogen administration is related to autoantibody production seen in autoimmune diseases. One possibility is that extrathymic DN CD4-8-(or single-positive) cffB T ceils with intermediate TCRs have a helper function of certain B calls (e.g., CD5 § B cells). Certain DN c~/15 T ceils have already been reported to be associated with the enhancement of autoantibody production by B ceils (43, 44) . In the autoimmune mice used in such studies, extrathymic o~/~ T cells with intermediate TCRs may be in activated states in the liver. The interaction of such extrathymic o~//3 T calls with certain B cells remains to be further investigated. At least, estrogen administration is known to augment antibody production of thymus-independent antigens (1, 45) . Extrathymic T cells may be a candidate in this case. In any case, the present results have led us to consider the possibility that physiological and pharmacological doses of estrogen might activate an extrathymic pathway for T cell differentiation. Such extrathymic o~/B T cells might be beneficial for the surveillance of atypical cells generated in vivo due to their autoreactivity. However, if an overstimulation of this pathway occurs in individuals with certain genetic or other traits, they may fall victim to autoimmune diseases. In such cases, it is probable that estrogen may act as one of the factors in the female preponderance of autoimmune diseases.
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